Status: Recruiting
Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
The goal of this study is to investigate the safety and tolerability of the topical application of SOF-SKN in healthy volunteers. The study will be divided into part 1 and part 2. Part 1, is a single ascending dose (SAD) design, while Part 2 is a multiple ascending dose (MAD) design.
Participants needed: 32
Trial details
Phase: Early Phase 1Age: 18-64Biological sex: AllType: InterventionalSponsor: Noxopharm LimitedUpdated: Jul 20, 2025Locations: 1
Eligibility criteria
Healthy Volunteers 18 to 64 years. [+5]
Allergic constitution. [+7]